SCHEMBL6258045

SCHEMBL6258045

CC(C)(C)OC(=O)c1cncc(C(=O)O)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.60
CYP2C9 P11712 1/20 0.60
HCAR2 Q8TDS4 6/20 0.52
ALDH1A1 P00352 4/20 0.47
KDM4E B2RXH2 3/20 0.47
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
POLB P06746 1/20 0.47
LMNA P02545 1/20 0.47
DDO Q99489 1/20 0.47
ATM Q13315 1/20 0.43
MKNK1 Q9BUB5 1/20 0.39
MKNK2 Q9HBH9 1/20 0.39
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
SLC7A5 Q01650 1/20 0.38
RAF1 P04049 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29521617 1.00 CYP2C19 (0.60) CYP2C19CYP2C9HCAR2ALDH1A1KDM4E
SCHEMBL6577887 0.83 TPMT (0.43) CYP2C19CYP2C9ALDH1A1KDM4EPOLB
SCHEMBL3403399 0.83 TPMT (0.43) CYP2C19CYP2C9ALDH1A1KDM4EPOLB
SCHEMBL5366124 0.82 ATM (0.43) CYP2C19CYP2C9HCAR2ALDH1A1KDM4E
SCHEMBL1185308 0.81 CYP2C19 (0.47) CYP2C19CYP2C9KDM4EATMCYP1A2
SCHEMBL29382818 0.81 CYP2C19 (0.69) CYP2C19CYP2C9ALDH1A1KMT2APOLB
SCHEMBL28585768 0.81 CYP2C19 (0.69) CYP2C19CYP2C9ALDH1A1KMT2APOLB
SCHEMBL30437614 0.81 HCAR2 (0.55) CYP2C19CYP2C9HCAR2ATMCYP1A2
SCHEMBL8486543 0.81 HCAR2 (0.55) HCAR2ATMNPC1RAB9ASMN1; SMN2
SCHEMBL308788 0.81 CYP1A2 (0.57) CYP2C19HCAR2KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114057739-A Diazepinone derivatives and their use in the treatment of hepatitis b infections 诺维拉治疗公司 2022-02-18 CN disclosed
CN-109641896-B Diazepinone derivatives and their use in the treatment of hepatitis b infections 诺维拉治疗公司 2021-09-21 CN disclosed
CN-109641896-A DIAZEPINONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF HEPATITIS B INFECTIONS 诺维拉治疗公司 2019-04-16 CN disclosed
WO-2005005437-A1 AN IMPROVED PROCESS FOR THE MANUFACTURE OF ISRADIPINE. SHASUN CHEMICALS AND DRUGS LIMITED (IN) 2005-01-20 WO disclosed